Oncological diseases

In 2013, more than 1.6 million patients were diagnosed with cancer in the US alone, and more than 500,000 patients died as a result of cancer. Cancer is one of the leading causes of mortality worldwide and new integrated treatments are increasingly used to combat its devastating effects. Hyperbaric oxygen therapy (HBO) is currently used in combination with conventional therapies, including radiology and chemotherapy, to determine the optimal dosage for patients, stimulate tumour regression and reduce the side effects of treatment. Cancer thrives in a hypoxic environment, and it turns out that HBO can increase oxygen levels to weaken tumours and reduce their aggressiveness.

STUDIES HAVE SHOWN THE BENEFICIAL EFFECT OF HBO IN PATIENTS WITH CANCER IN THE FOLLOWING CASES:

IMPROVING THE EFFECTS OF CONVENTIONAL CANCER TREATMENT WITH HBO

Reduces tumour hypoxia: Better radiation therapy results, better chemotherapy results, improves brain treatment
Reduces drug resistance of tumours
Allows you to achieve the optimal dosage of the drug
Enhances postoperative activation of fibroblasts

REDUCING TUMOUR AGGRESSIVENESS WITH HBO

Weakens hypoxic tumours
Targets metastatic tumours

INCREASING THE ACTIVITY AND FUNCTIONALITY OF NK CELLS (LYMPHOCYTES) BY HBO

Increases the formation of oxygen radicals
Enhances the effect of apoptosis
It has a regressive effect on tumour volume

PREVENTION OF CANCER WITH HBO

Reduces the level of inflammatory markers
Normalizes oxygen levels inside the cell
Stimulates cellular detoxification
Reduces the risk of pathogenic inflammatory tumours
Supports energy cellular processes enabling optimal DNA reconstruction

REDUCING THE SIDE EFFECTS OF CONVENTIONAL CANCER TREATMENT WITH HBO

Suppresses side effects of radiation therapy
Suppresses the side effects of chemotherapy
Accelerates postoperative healing and prevents infection
Reduces symptoms of neurocognitive dysfunction (Chemo-Brain Syndrome)

HBO IMPROVES THE EFFECTS OF INTRAVENOUS CANCER TREATMENT

Enhances the effect of therapy with intravenous administration of vitamin C
Increases the uptake (“uptake”) of chemotherapy

STUDY: HBO’S ROLE IN REDUCING ATHEROSCLEROSIS AND INFLAMMATION

A non-randomized trial conducted on 26 patients to evaluate the effectiveness of radiotherapy in combination with HBO in patients with malignant glioma. Fifteen patients received daily radiotherapy after receiving HBO, and fourteen other patients received radiotherapy without HBO. In the HBO group, 11 out of 15 patients showed ≥ 50% tumour regression. In the non-HBO group, only 4 out of 14 patients (29 percent) experienced tumour regression. Median survival in patients receiving HBO doubled compared to the group of patients without HBO (24 months vs. 12 months). No serious side effects were reported in the HBO group. This fact presents another argument in favour of HBO as a treatment with a beneficial effect for patients with malignant glioma.